⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VKTX News
Viking Therapeutics, Inc
Form 8-K
sec.gov
LGNZZ
LGND
LGNYZ
LGNXZ
LGNDZ
VKTX
Form 8-K
sec.gov
VKTX
Viking Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
prnewswire.com
VKTX
The Longevity Trade Is No Longer a Buzzword — It's a $120 Billion Market, and the FDA Just Cleared the First Cellular Rejuvenation Trial
globenewswire.com
LLY
NVO
VKTX
LGVN
Viking Therapeutics to Participate at Upcoming Investor Conferences
prnewswire.com
VKTX
Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-2 Trial of VK2735
prnewswire.com
VKTX
Viking Therapeutics to Participate at Upcoming Investor Conferences
prnewswire.com
VKTX
Vektor Medical Announces EP Europace Publication: vMap-Guided Ablation Associated with Improved One-Year Arrhythmia-Free Survival in Unstable Ventricular Tachycardia Patients
businesswire.com
VKTX
Accessible Health Platforms Gain Scale Across $6T Health and Wellness Market
prnewswire.com
PODD
VKTX
AMRX
PBH
Viking Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update
prnewswire.com
VKTX